HEALTH PROFESSIONAL · SOURCE READING

Treatment of Medullary Thyroid Carcinoma

Source: Childhood Thyroid Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 3, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Medullary thyroid carcinomas are commonly associated with the MEN2 syndrome. For more information, see Childhood Multiple Endocrine Neoplasia (MEN) Syndromes Treatment and Multiple Endocrine Neoplasia Type 2 (MEN2).

Source links and citations

Treatment options for medullary thyroid carcinoma include the following:

Surgery.

Source links and citations

Surgery

Tyrosine kinase inhibitor (TKI) therapy.

Source links and citations

Tyrosine kinase inhibitor (TKI) therapy

Continue within this section

Surgery →Tyrosine kinase inhibitor (TKI) therapy →Treatment options under clinical evaluation for medullary thyroid carcinoma →

Preserved source evidence · Not medical advice